Home › Funds › Biondo Investment Advisors, LLC › VRTX

Biondo Investment Advisors, LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Biondo Investment Advisors, LLC reported holding 24,195 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$12.6M, representing 1.51% of its reported portfolio and ranking #22 among its reported holdings. Biondo Investment Advisors, LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)24.20K sh
Reported value held$12.65M
Portfolio Weight1.51%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Biondo Investment Advisors, LLC's VRTX position evolved

Biondo Investment Advisors, LLC first disclosed a stake in VRTX in Q3 2023 at 665 shares (US$231K). The position peaked in Q3 2026 at 24,195 shares, worth US$12.6M. Across 13 filings, Biondo Investment Advisors, LLC increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 24,195 shares valued at US$12.6M — a reduction of -950 shares quarter over quarter.. Notable position changes include a 3574% increase in Q2 2024 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 665 $231.25K New
Q4 2023 665 $270.58K Hold
Q1 2024 665 $277.98K Hold
Q2 2024 24.43K $11.45M Add
Q3 2024 25.09K $11.67M Add
Q4 2024 25.28K $10.18M Add
Q1 2025 25.15K $12.19M Reduce
Q2 2025 24.93K $11.10M Reduce
Q3 2025 25.07K $9.82M Add
Q4 2025 25.14K $11.40M Hold
Q1 2026 25.32K $11.30M Add
Q2 2026 25.14K $12.49M Reduce
Q3 2026 24.20K $12.65M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Biondo Investment Advisors, LLC held VRTX?

Biondo Investment Advisors, LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Biondo Investment Advisors, LLC's current position in VRTX?

As of Q3 2026, Biondo Investment Advisors, LLC holds 24.20K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $12.65M, representing 1.51% of its reported portfolio and ranking #22.

Has Biondo Investment Advisors, LLC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Biondo Investment Advisors, LLC reduced its position in VRTX. The position peaked in Q3 2026 at 24.20K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.